Scientists are calling for urgent international dialogue and greater public engagement as concerns grow over invisible contamination, with growing recognition that business leaders must play a central role in responding responsibly to emerging risks.
Microplastics are no longer something we can simply clean up or manage at the margins. They are being found inside the human body – in blood, organs and even placentas – at a time when the global burden of disease is rising.
Around 20 million new cancer cases were recorded worldwide in 2022 and that number is expected to reach more than 35 million by 2050 – an increase of approximately 77%, according to the World Health Organization. Cancer already accounts for around one in six deaths globally, placing growing pressure on health systems and societies.
The causes are complex, spanning ageing populations, lifestyle factors and improved detection. But one factor is increasingly difficult to ignore – long-term exposure to environmental and industrial materials that accumulate silently over time.
RESPONSIBLE LEADERSHIP MATTERS
For businesses, this marks a deeper and more uncomfortable shift. Nanoplastics are not an isolated issue. They are part of a broader pattern in which modern materials, chemicals and industrial processes create forms of contamination that move through air, water, food systems and into people.
What was once considered environmental impact is now becoming human exposure. And with that shift comes a fundamental question of responsibility.
If products, materials and processes contribute – even indirectly – to long-term human exposure, then the role of business cannot be limited to compliance or profitability alone. It extends to understanding, reducing and, where possible, preventing harm.
This is not simply a regulatory issue. It is a question of responsible leadership.
NANOPLASTICS: HIDDEN CONNECTIONS & EMERGING RISKS
Last month, on February 24, 2026, the European Parliament in Brussels hosted a high-level international conference titled “Nanoplastics: Hidden Connections and Emerging Risks”, bringing together scientists, policymakers and civil society representatives to examine the scale of the challenge.
Organised by MEP Ondřej Knotek, in collaboration with the ALLATRA Global Research Center, the conference highlighted a growing consensus: Micro- and nanoplastics are not just an environmental issue. They are an emerging systemic risk for business, health and society.
DIRECT BUSINESS IMPLICATIONS
For decades, plastic pollution was understood as something external – visible in oceans, landfills and ecosystems. That boundary has now collapsed.
Experts highlighted that micro- and nanoplastics are present in air, water, food systems and human tissues, transforming them into a cross-sector challenge affecting industries from food and fashion to pharmaceuticals and logistics.
“When they enter the bloodstream, these particles can circulate through the body. They’ve been detected across multiple tissues and organ systems, including the liver, kidneys, heart and blood vessels, placenta and breast milk,” explained Dr John Ahn, expert in chemical engineering and sustainable technologies, and representative of the Scientific Advisory & Research Council of ALLATRA Global Research Center.
For businesses, the implication is direct: if these particles are in people, they are entering through products, materials and systems companies design, produce and distribute. “Consequently, micro- and nanoplastics should be considered not as a local waste problem, but as a new physical and chemical factor on a planetary scale,” noted Anna Kotlyar, representative of the Scientific Advisory & Research Council of ALLATRA Global Research Center.
CONVERGING HEALTH & ENVIRONMENTAL RISKS
This issue is emerging alongside a broader shift in global health trends. While population growth and ageing remain major drivers, researchers increasingly point to environmental risk factors – including air pollution and chemical exposure – as contributing elements in rising disease burden.
Early-onset cancers are also increasing, particularly among younger populations, raising further questions about long-term exposure to environmental and industrial contaminants. Nanoplastics are now part of that wider picture.
As biochemist and representative of the Scientific Advisory & Research Council of ALLATRA Global Research Center, Alexander Masny, explained: “The surface charge of micro- and nanoplastics plays an important role in determining their behaviour in biological systems.”
Their ability to penetrate cells and affect mitochondrial function is raising concerns about links to inflammation, metabolic disruption and disease pathways – although further research is needed. Among the most striking findings presented was research by Professor Antonio Ragusa, also the first scientist to identify microplastics in the human placenta, highlighting the direct implications of plastic pollution for human reproduction and development. “Constant exposure to plastic particles has raised concerns about human health, particularly when it comes to birth outcomes… It is like having a cyborg baby: no longer composed only of human cells, but a mixture of organic and inorganic compounds,” shared Professor Ragusa,
CORPORATE RESPONSIBILITY
Nanoplastics are not an isolated issue. They are part of a broader transition from visible pollution to invisible exposure.
From persistent chemicals such as PFAS to airborne particulates and synthetic byproducts, a growing class of materials is moving beyond environmental concern into questions of human health, liability and corporate responsibility.
Pollution no longer ends in ecosystems. It increasingly accumulates in people.
HIDDEN LIABILITY
Unlike visible plastic waste, nanoplastics are generated through everyday industrial processes – from synthetic textiles shedding fibres to packaging degradation and transport-related abrasion. That makes them difficult to trace, but increasingly difficult to ignore.
As scrutiny grows, companies may face:
- Product liability risks, particularly in food, cosmetics and healthcare
- Stricter regulatory standards on materials and manufacturing
- Investor demands for transparency on microplastic exposure
For many executives, the trajectory will feel familiar. Chemicals such as PFAS – once widely used and poorly understood – are now associated with long-term health risks including cancers and endocrine disruption, and have become the subject of billions in litigation worldwide. Nanoplastics could follow a similar path: early scientific warnings, slow policy response, then rapid legal and reputational escalation.
MOST EXPOSED INDUSTRIES
Several sectors are particularly exposed to these risks. They include:
- Food and beverage
- Fashion and textiles
- Beauty and personal care
- Pharmaceuticals and healthcare
- Logistics and automotive
In each case, the issue is not only environmental footprint, but direct human exposure.
ENVIRONMENTAL & ECONOMIC SYSTEMS UNDER PRESSURE
The risks extend beyond human health into the systems that underpin the global economy. As Dr Jan Kára, also a representative of the Scientific Advisory & Research Council of ALLATRA Global Research Center, warned: “One fact we already know is that micro- and nanoplastics do affect water cycle and may contribute to more frequent creation of hail and creation of larger hailstones. According to our estimates, the window of opportunity for substantial progress is several years, not decades.”
For sectors dependent on climate stability – including agriculture, insurance and infrastructure – this introduces a new layer of systemic uncertainty.
FRAGMENTED GLOBAL STANDARDS
Despite mounting evidence, global standards remain fragmented. Dr Kára stated: “We lack unified European standards for monitoring plastic particles under 10 microns… We cannot compare data from different countries… We also lack standardised protocols for studying health impacts… Without unified protocols, we cannot obtain reliable and reproducible results for making informed decisions.”
As measurement improves, companies may face new requirements around disclosure, monitoring and risk mitigation.
MEP Ondřej Knotek suggested the issue remains under-addressed because it is not immediately visible: “There are other elements that are also involved in climate stability, and this is fully being ignored. So, it is a strong occasion for the public to be more vocal on this topic. That’s my answer.”
REGULATORY GAPS
Conference participants highlighted a critical gap in global preparedness: the absence of unified standards for monitoring micro- and nanoplastics – particularly particles smaller than 10 microns – and the lack of agreed protocols for assessing their impact on human health. The behaviour of nanoplastics adds further complexity, as their surface charge allows them to interact with surrounding environments, including living tissues, in ways that are not yet fully understood.
Experts called for stronger international cooperation, expanded research and greater public awareness to support evidence-based policymaking.
MORAL & CORPORATE RESPONSIBILITY
MEP Ondřej Knotek emphasised the need for policy to keep pace with emerging science, while Pastor Mark Burns, globally recognised Christian leader and international speaker, highlighted the “moral obligation to protect life, to protect health and to speak early – not after the cost becomes irreversible.”
Maryna Ovtsynova, President of ALLATRA International Public Movement and a global expert in risk and climate strategy, emphasised the need for coordinated global action, scientific collaboration and transparency. In a world where business decisions increasingly shape human exposure, responsibility is no longer abstract.
Micro- and nanoplastics are the kind of risk that builds quietly – until it does not. They are already embedded in the environment, the economy and the human body, at a time when the global burden of disease is rising sharply and scrutiny of environmental contributors is intensifying. For global business, the question is no longer whether this will matter, but who acts early and who is left explaining why they did not.
GUIDANCE FOR RESPONSIBLE ORGANISATIONS
So what should responsible businesses and their leaders do now? For many organisations, the instinct in the face of emerging risk is to wait for clearer science, for regulatory direction, or for competitors to move first. But the history of environmental and health-related crises suggests that delay often carries the greatest long-term cost.
A more responsible approach, however, is structured, deliberate and forward-looking. Responsible leaders should instead consider the following:
1. Understand your exposure
The starting point is visibility. Businesses need to look beyond immediate operations to identify where micro- and nanoplastics may enter products, processes and environments, from raw materials and packaging to water systems and end use. For many companies, this will reveal that exposure is not isolated, but systemic.
2. Map and assess supply chain risk
Nanoplastics are often generated upstream. Synthetic materials, textiles, tyres, coatings and plastic packaging are all potential sources. Mapping these inputs is not simply a compliance exercise; it is a way of identifying where future risk and accountability may emerge.
3. Invest in safer materials and innovation
Early investment in alternative materials, improved filtration technologies and circular design approaches can reduce exposure at source. Companies that act now are not only mitigating risk, but positioning themselves ahead of regulatory and market shifts.
4. Strengthen transparency and disclosure
As scientific understanding evolves, expectations are changing. Investors, regulators and consumers increasingly expect companies to demonstrate transparency and awareness of emerging risks, even where formal standards are not yet in place. Proactive disclosure builds trust and reduces the risk of future reputational damage.
5. Avoid greenwashing and greenhushing
As awareness of environmental and health risks grows, so too does scrutiny of how companies communicate their response. Overstating progress or making unsubstantiated claims – often described as ‘greenwashing’ – carries increasing reputational and regulatory risk. But the opposite response, sometimes referred to as ‘greenhushing,’ where companies avoid communicating altogether, can be equally problematic.
Silence does not eliminate risk. It can increase mistrust. For emerging issues such as nanoplastics, where scientific understanding is still evolving, the most effective approach is neither exaggeration nor avoidance, but transparency grounded in evidence. Responsible businesses should communicate clearly about what they know, what they do not yet know, and what they are doing to address the issue.
6. Engage in shaping standards and policy
Businesses that participate in the development of emerging frameworks – working with scientists, regulators and industry peers – are more likely to influence outcomes than those that respond after the fact. Engagement is not optional; it is part of responsible leadership.
7. Integrate contamination risk into ESG strategy
Beyond carbon and climate, issues of material safety, human exposure and long-term health impact are becoming central to ESG. Treating nanoplastics as an emerging priority ensures that risk management reflects the full scope of environmental and social impact.
8. Prepare for regulation and potential liability
The trajectory of past environmental risks suggests that early scientific concern can evolve into regulatory action and litigation. Scenario planning – including potential compliance requirements, product reformulation and legal exposure – is essential for long-term resilience.
9. Recognise responsibility beyond compliance
Ultimately, this is not just a technical or regulatory challenge. If business activities contribute – even indirectly – to human exposure, then responsibility extends beyond meeting minimum standards. It includes actively seeking to understand, reduce and, where possible, prevent harm.
RELATED ARTICLES
This year, World Cancer Day highlights that every cancer experience is unique, and workplaces must respond accordingly.
Why employers must lead the charge in creating cancer-ready workplaces.
As more organisations tout their commitments to diversity, some face accusations of “purple washing” as they are publicly claiming to support disability inclusion without putting in the real work.
Companies integrating climate and ESG-related metrics into their executives’ compensation plans more than doubled over the past two years, according to report.
A recent report has revealed that global greenwashing has declined for the first time in six years, however the severity of incidents is rising.
Greenhushing: Most businesses avoid greenwashing by keeping quiet on ESG matters.
AI, ESG, DEI and transparency are now among the top considerations for investors, reveals global study.
Sign up for our newsletter
